Boehringer Ingelheim is committed to addressing areas of unmet medical need and helping people prioritize their health through innovative programs and strategic collaborations. One example is its alliance with Eli Lilly and Company (Lilly) to advance education around the interconnectedness of cardio-renal-metabolic (C-R-M) conditions including type 2 diabetes, heart failure and chronic kidney disease (CKD).

The companies are proud to partner with the AAFP Foundation, recognizing that family physicians and primary care physicians serve a key role in understanding and managing the unique needs of their patients and communities.

More than 35 million adults in the United States have CKD, with underserved communities often disproportionately affected. Among these adults, roughly 90 percent are unaware of their condition, as patients often remain asymptomatic until their disease has advanced to a later stage.

Two-thirds of kidney disease cases are caused by type 2 diabetes or high blood pressure. Family physicians can significantly influence the steps their patients take to prevent, detect and manage CKD and the chronic conditions that contribute to it — another reason Boehringer Ingelheim and Lilly find great value in teaming up with the AAFP Foundation.

To raise awareness of CKD and promote early detection, Boehringer and Lilly launched It Takes 2, an award-winning, unbranded campaign that targets both patients and health care providers.

The campaign features a remix of the hit hip-hop song from the 1980s, “It Takes Two” by the original artist, Rob Base, who delivers messages about the importance of proactively screening for kidney disease.

Boehringer-Lilly recently expanded this effort with Spanish-language websites and translated materials and is developing new tactics to further improve access to this vital information.

Through its ongoing partnership with the AAFP Foundation, Boehringer Ingelheim is making a meaningful impact on the health of millions of Americans.